Physician
Katisha T Vance, M.D.
According to 2025 Medicare claims, Katisha Vance, M.D. (NPI: 1467526442) practices medical oncology in the Birmingham, AL market, with the plurality of this provider's patient population coming from Jefferson, AL. This provider's primary affiliated billing organization is BIRMINGHAM HEMATOLOGY ONCOLOGY ASSOC LLC (NPI: 1841216389; TIN: 522170293) and primary practice location at 35211-1323.
Vance's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 232 traditional Medicare patients, billed 132,258 HCPCS/CPT codes, and received $2,208,271 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,548 prescription claims across 435 beneficiaries totaling $7,359,961 in drug costs, led by Revlimid (Lenalidomide). 2021 DME data shows 70 claims. Open Payments data shows 63 records totaling $83,164. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.
Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,091,245 to $7,359,961. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $7,008 to $1,163.